Pages that link to "Q28086933"

The following pages link to SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function (Q28086933):

Displaying 19 items.

• Anti-Double-Stranded DNA IgG Participates in Renal Fibrosis through Suppressing the Suppressor of Cytokine Signaling 1 Signals. (Q33740586) (← links)
• SOCS1 is a negative regulator of metabolic reprogramming during sepsis (Q33877757) (← links)
• Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma. (Q35763914) (← links)
• Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells (Q36119606) (← links)
• The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease (Q38767234) (← links)
• Genetics of primary sclerosing cholangitis and pathophysiological implications (Q39178438) (← links)
• Negative Regulation of Cytokine Signaling in Immunity (Q39440197) (← links)
• TLR8 Couples SOCS-1 and Restrains TLR7-Mediated Antiviral Immunity, Exacerbating West Nile Virus Infection in Mice (Q40082187) (← links)
• A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes. (Q43283307) (← links)
• Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells (Q47094073) (← links)
• Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus (Q47151871) (← links)
• Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy. (Q49058263) (← links)
• Macrophages and the Recovery from Acute and Chronic Inflammation (Q51270292) (← links)
• A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis (Q58118524) (← links)
• Peptides as Therapeutic Agents for Inflammatory-Related Diseases (Q58749714) (← links)
• Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells (Q61813961) (← links)
• Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer (Q64054927) (← links)
• Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease (Q88608456) (← links)
• A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis (Q89892713) (← links)